Saxenda or Mounjaro - Lowest Price UK | Cured Pharmacy
Cheapest Saxenda or Mounjaro UK Price - From £124.99
Compare Saxenda and Mounjaro at the cheapest UK price from £124.99, plus £20 off your first order with code Weightlossnew.
Takes less than 2 minutes to complete 100% online
Treatment from £124.99
Check if you're eligible
Your BMI
26.8ⓘ Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.
Our Pricing
Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.
2.5mg
1 pen • 4 Weeks
£31.25 / Per Week
Your starting dose – designed to help your body adjust gently to treatment
5mg
1 pen • 4 Weeks
£39.75 / Per Week
First step up – builds on your progress as your body adapts to treatment
7.5mg
1 pen • 4 Weeks
£50.00 / Per Week
Mid-range dose – for continued progression and enhanced results
10mg
1 pen • 4 Weeks
£56.25 / Per Week
Higher strength dose – supports significant weight loss progress
12.5mg
1 pen • 4 Weeks
£62.50 / Per Week
Advanced dose – for patients requiring stronger therapeutic effect
15mg
1 pen • 4 Weeks
£66.75 / Per Week
Maximum dose – the highest available strength for optimal results
0.25mg
1 pen • 4 Weeks
£17.25 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
0.5mg
1 pen • 4 Weeks
£19.75 / Per Week
First step up – continues building tolerance for long-term success
1mg
1 pen • 4 Weeks
£24.75 / Per Week
Mid-range dose – where most patients start seeing meaningful results
1.7mg
1 pen • 4 Weeks
£37.25 / Per Week
Higher strength – supports accelerated weight loss progress
2.4mg
1 pen • 4 Weeks
£44.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
1.5mg
1 pen • 4 Weeks
£20.75 / Per Week
Your starting dose – eases your body into treatment with minimal side effects
4mg
1 pen • 4 Weeks
£27.50 / Per Week
First step up – continues building tolerance for long-term success
9mg
1 pen • 4 Weeks
£35.00 / Per Week
Mid-range dose – where most patients start seeing meaningful results
25mg
1 pen • 4 Weeks
£49.75 / Per Week
Maximum dose – the highest available strength for optimal weight management
Saxenda or Mounjaro - Lowest Price UK Assured
Published on: June 03, 2026
Searching for saxenda or mounjaro lowest price uk options? At Cured Pharmacy, we guarantee the lowest prices on both medications — Mounjaro from £124.99 and Saxenda from £135.00 — with transparent upfront pricing, free clinical consultation by UK prescribers, and discreet next-day delivery across the UK.
Saxenda or Mounjaro Lowest Price UK: Understanding Your Options
Both Saxenda and Mounjaro are MHRA-licensed injectable medications for weight management, but they differ significantly in mechanism, efficacy, and cost. Saxenda contains liraglutide, a GLP-1 receptor agonist administered daily, whilst Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist requiring only weekly injections [1].
Clinical trial data demonstrates substantial differences in weight loss outcomes. In the SURPASS-2 trial, tirzepatide produced average weight reductions of up to 22.5% over 72 weeks at the highest dose, compared to 12.4% average weight loss with liraglutide in the SCALE trial [1][2]. These efficacy differences are reflected in pricing structures across UK pharmacies.
At Cured Pharmacy, we've structured our pricing to ensure accessibility to both options. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees clinical assessments to determine which medication suits your individual circumstances, medical history, and budget considerations.
How Mounjaro and Saxenda Work Differently
Saxenda's active ingredient liraglutide mimics the GLP-1 hormone naturally produced in your gut after eating. This single-pathway mechanism slows gastric emptying, reduces appetite signals to the brain, and improves glycaemic control [2]. Patients typically start on 0.6mg daily and titrate up to the maintenance dose of 3mg over five weeks.
Mounjaro represents a newer therapeutic class. Tirzepatide activates both GIP and GLP-1 receptors simultaneously, producing enhanced metabolic effects compared to GLP-1 agonists alone [1]. This dual action explains the superior weight loss outcomes observed in head-to-head trials, though both medications require prescription and clinical monitoring.
The dosing convenience differs markedly: Saxenda requires daily subcutaneous injections using pre-filled pens, whilst Mounjaro is administered once weekly. For patients concerned about injection frequency or those with busy lifestyles, this practical difference often influences treatment choice alongside clinical considerations.
Mechanism of Action: GLP-1 vs Dual GIP/GLP-1
GLP-1 receptor agonists like Saxenda work by binding to receptors in the pancreas, stomach, and brain regions controlling appetite. The resulting cascade includes increased insulin secretion when blood glucose rises, delayed stomach emptying creating prolonged satiety, and direct appetite suppression through hypothalamic pathways [2].
Tirzepatide's additional GIP receptor activation enhances these effects. GIP contributes to insulin secretion, improves lipid metabolism, and may influence central appetite regulation through complementary pathways. This dual mechanism explains why clinical trials consistently show greater weight loss with tirzepatide compared to single GLP-1 agonists [1][3].
Comparing Clinical Trial Results and Real-World Efficacy
The SCALE Obesity and Prediabetes trial enrolled 3,731 adults without type 2 diabetes, demonstrating that liraglutide 3mg daily produced average weight loss of 8.4kg (8% body weight) versus 2.8kg with placebo over 56 weeks [2]. Approximately 63% of liraglutide-treated patients achieved at least 5% weight loss, meeting the clinical threshold for meaningful health benefits.
In contrast, the SURMOUNT-1 trial showed tirzepatide achieving dose-dependent weight reductions: 15% average weight loss at 5mg weekly, 19.5% at 10mg, and 20.9% at 15mg over 72 weeks [1]. These results positioned tirzepatide as the most effective weight loss medication currently licensed in the UK, subject to individual response and tolerability.
Real-world effectiveness depends on multiple factors beyond the medication itself. UK prescribers emphasise that both treatments work optimally alongside reduced-calorie diets and increased physical activity. Clinical trials required participants to receive lifestyle counselling, and similar behavioural modifications remain essential for sustained weight management outcomes [3][4].
What Weight Loss Can You Realistically Expect?
Individual responses vary considerably, but clinical trial averages provide useful benchmarks. With Saxenda, patients maintaining the 3mg daily dose typically lose 5-10% of their starting weight over six months when combined with lifestyle modifications [2]. Those not achieving at least 5% weight loss after 12 weeks at the full dose should discuss alternative options with their prescriber.
Mounjaro users in clinical trials experienced progressive weight loss over 72 weeks, with most weight reduction occurring in the first 36 weeks [1]. The highest licensed dose (15mg weekly) produced average losses exceeding 20% of baseline weight, though your UK prescriber will determine the appropriate starting and maintenance dose based on efficacy and side effect tolerance.
| Treatment | Active Ingredient | Dosing Frequency | Average Weight Loss | Starting Price |
|---|---|---|---|---|
| Mounjaro | Tirzepatide (GIP/GLP-1) | Once weekly injection | Up to 22.5% (72 weeks) | From £124.99 |
| Saxenda | Liraglutide (GLP-1) | Daily injection | Average 8% (56 weeks) | From £68.00 |
| Wegovy | Semaglutide (GLP-1) | Once weekly injection | Average 15% (68 weeks) | From £69.00 |
| Wegovy Oral | Semaglutide (oral) | Daily tablet | Similar to injectable | From £69.00 |
| Orlistat | Orlistat (lipase inhibitor) | Three times daily | Average 3kg additional loss | From £32.00 |
Side Effects and Safety Considerations
Both medications share similar gastrointestinal side effects due to their GLP-1 activity. The most common adverse events include nausea, diarrhoea, constipation, vomiting, and abdominal discomfort [1][2]. These symptoms typically emerge during dose escalation and diminish over several weeks as your body adjusts to the medication.
Saxenda's daily dosing allows gradual titration from 0.6mg to 3mg over five weeks, which helps minimise initial side effects. Mounjaro similarly employs dose escalation, starting at 2.5mg weekly and increasing every four weeks if tolerated. Approximately 5-10% of patients discontinue treatment due to persistent gastrointestinal symptoms in clinical trials [1][2].
More serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Both medications carry warnings about thyroid C-cell tumours based on rodent studies, though no causal relationship has been established in humans [3]. Your UK prescriber will review your complete medical history during the consultation to identify any contraindications.
Pricing Structure and Value Considerations
At Cured Pharmacy, Mounjaro pricing starts from £124.99 per month, reflecting the cost of this newer dual-agonist therapy and its once-weekly convenience. The specific price depends on your prescribed dose — 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg — which your UK prescriber determines based on your response and tolerance during treatment.
Saxenda represents a more budget-friendly option for many patients, with competitive UK pricing that makes daily GLP-1 therapy accessible. Whilst the per-injection cost is lower, the daily administration means you'll use more pens monthly compared to Mounjaro's weekly schedule. Our transparent pricing structure shows exact costs before you complete your clinical assessment.
When evaluating value, consider both the financial cost and the clinical efficacy data. Mounjaro's superior weight loss outcomes in trials may justify the higher price for patients seeking maximum results, whilst Saxenda offers proven efficacy at a lower entry point. Many patients successfully achieve their weight goals with either medication when combined with sustainable lifestyle changes [4].
Additional Weight Loss Treatment Options
Beyond Mounjaro and Saxenda, Cured Pharmacy offers Wegovy (semaglutide), another once-weekly GLP-1 injection producing average weight loss of 15% in the STEP trials [4]. Wegovy's efficacy sits between Saxenda and Mounjaro, providing a middle-ground option for patients considering injectable therapies.
For those preferring oral medications, we also dispense Orlistat and Xenical (both containing orlistat, a lipase inhibitor), plus the newer Wegovy oral tablets. Orlistat works through a completely different mechanism — blocking dietary fat absorption rather than affecting appetite hormones — and may suit patients unable to tolerate GLP-1 medications or those seeking non-injectable options.
How to Start Treatment at Cured Pharmacy
Beginning your weight loss journey with Mounjaro or Saxenda requires three simple steps. First, complete our free online consultation questionnaire, which takes under three minutes and covers your medical history, current medications, weight loss goals, and any relevant health conditions. This information allows our UK-registered prescribers to assess your suitability safely and effectively.
A qualified UK prescriber reviews your consultation within hours. If Mounjaro or Saxenda is clinically appropriate, they'll issue an NHS-valid prescription and determine your starting dose. Should either medication be unsuitable based on your medical profile, the prescriber will explain why and may suggest alternative treatments from our weight loss range. All prescription decisions prioritise your safety and comply with MHRA guidelines.
Once approved, our GPhC-registered pharmacy (registration 9012511) dispenses your medication in discreet, unmarked packaging. We offer next-day delivery across the UK, with tracking provided for all orders. Your first pack includes the pre-filled injection pens, needles, and comprehensive administration instructions. Our clinical team remains available throughout your treatment for any questions or concerns.
Scientific References
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
- Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
- Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
- Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
- NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
- NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
- NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.
Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including adherence to lifestyle modifications. Cured Pharmacy operates under GPhC registration 9012511 with superintendent pharmacist Tarun Kumar (GPhC 2233073).
Trusted by thousands
Real people, real results
Jane L.
"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."
Ann-Marie
"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."
Sacha W.
"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."
Kimberly G.
"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"
Jennifer
"Great really helps cure those nasty habits can't wait for my next mounjaro pen."
How it Works?
Select from our recommended UK-licensed medications.
1Choose your treatment

Select safe UK treatments. Quick answers.
2Answer quick questions

We will deliver direct to you as quickly as tomorrow.
3Get it delivered fast

Start Your Assessment For Weight Loss
Start your journey to better health today.
- Reviewed by UK-based prescribers
- Takes under 3 minutes
- Discreet Packaging
Start Your Journey To Better Health Today
Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.
Start My Assessment Log in to Your AccountFaq
Medically reviewed by
Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)
Reviewed on: June 03, 2026
Last updated on 13 August 2026.
Review History
Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.
Why this page was updated on 13 August 2026
Content checked and updated as part of our periodic review, to ensure accuracy and currentness.
Current version (13 August 2026)
Edited by: The Editorial Team
Medically reviewed by:
Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist
How we source info.
When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.